tm logo
EPISCORE
Live/Registered
REGISTERED

on 26 Nov 2024

Last Applicant/ Owned by

Pekeris 3

Rehovot

IL

7670203

Serial Number

97842069 filed on 16th Mar 2023

Registration Number

7575466 registered on 26th Nov 2024

in the Principal Register

Filing Basis

1. intent to use

Disclaimer

NO DATA

EPISCORE

Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD) Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for thediagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease andprognosis of expected pro Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for thediagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease andprognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of thedetection and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurologicaldisease; providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease(COPD) and autoimmune disease and neurological disease; providing a website featuring information in the fields of the diagnosisand treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD)


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuringchanges associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune diseaseand neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronicobstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic assay kits comprisedof medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions,chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for usein disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmunedisease and neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing ofbodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease(COPD), autoimmune disease and neurological disease in the field of cancer detection, detection of or chronic obstructivepulmonary disease (COPD), autoimmune disease and neurological disease; diagnostic reagents for medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97842069

Mark Type

No Service Mark

Attorney Docket Number

No 375.026820

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Nov 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
26th Nov 2024REGISTERED-PRINCIPAL REGISTER
24th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24th Sep 2024PUBLISHED FOR OPPOSITION
04th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
18th Aug 2024TEAS/EMAIL CORRESPONDENCE ENTERED
18th Aug 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
17th Aug 2024ASSIGNED TO LIE
04th Mar 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED